Clinical & Diagnostic
Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfiz...
March 14, 2023 | News
Through the partnership, Qritive's artificial intelligence modules and Corista's DP3® image management platform will be integrated to help pathologist'...
March 14, 2023 | News
The trial met its primary endpoint with Nefecon demonstrating a highly statistically significant benefit over placebo (p value < 0.0001) in estimated gl...
March 14, 2023 | News
Under the terms of the license agreement, AnnJi will receive upfront payments of $3 million and is entitled to receive future development, regula...
March 13, 2023 | News
The funds raised in this round will primarily support upcoming Phase I/II clinical trials in both China and the U.S. and the identification of cl...
March 11, 2023 | News
Leica Microsystems, a leader in microscopy and scientific instrumentation, has entered a partnership with Mentoring Hessen and strengthened its efforts to ...
March 09, 2023 | News
The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker®...
March 09, 2023 | News
TransCure bioServices has developed cell line-derived xenograft (CDX) mouse models that will change how researchers tackle the preclinical studies of cance...
March 07, 2023 | News
The collaboration will expand C2i’s global reach and bring MRD cancer monitoring capabilities for solid tumors to Japan C2i Genomics...
March 03, 2023 | News
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Kevzara® (...
March 01, 2023 | News
Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...
March 01, 2023 | News
A GSK-sponsored Ipsos-MORI survey revealed only 3% of Singaporeans aged 50-79 years believe they are at high risk of developing shingles in the next 12 mon...
February 28, 2023 | News
GC Biopharma Corp. (006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that it has signed an Asset Purchase ...
February 28, 2023 | News
The clinical trial to be conducted by Peter Mac will be the first time a CAR-T cell therapy product containing the genetic modifications incorporated into ...
February 27, 2023 | News
Most Read
Bio Jobs
News